Types of retinoblastoma

Last medical review:

There are 2 different types of retinoblastoma. The type that develops depends on where and when the RB1 mutation occurs and whether the mutation is inherited (passed to a child from a parent).

Non-heritable retinoblastoma

Non-heritable retinoblastoma (also called sporadic retinoblastoma) happens by chance. About half the number of children with retinoblastoma have non-heritable retinoblastoma.

Children are born with 2 normal copies of the RB1 gene. A mutation of both copies of the RB1 gene in a retinoblast cell causes a retinoblastoma tumour to form in the eye.

Sometimes non-heritable retinoblastoma can happen even though the RB1 genes are normal. In this case, there are too many copies of the gene called MYCN. When there are too many copies of a gene, itʼs called an amplification. The amplification of the MYCN gene causes retinoblastoma that grows quickly and usually occurs in children around the age of 4 months old.

Children with non-heritable retinoblastoma develop one tumour in one eye (called unilateral retinoblastoma). They will not pass the RB1 mutation to their children.

Heritable retinoblastoma

Heritable retinoblastoma is the result of a mutation in the RB1 gene that is either inherited, the mutation happens in the egg or sperm before or soon after conception (called a germline mutation), or when the embryo is developing. About half of children with retinoblastoma have heritable retinoblastoma.

In all cases of heritable retinoblastoma, a child is born with one copy of the RB1 mutation in all or a portion of all cells of the body. This increases the risk of developing cancer in other parts of the body later in life. A mutation of the second copy of the RB1 gene then occurs in retinoblasts and causes retinoblastoma to form. In about 10% of children with heritable retinoblastoma, the mutation of the second copy of the RB1 gene was inherited from a parent. When this happens, it’s called familial retinoblastoma.

Children with heritable retinoblastoma can have more than one tumour, and these tumours can develop in one or both eyes (called bilateral retinoblastoma).

Children with heritable retinoblastoma can pass the RB1 mutation on to their children. They also have a greater risk of developing a tumour in the pineal gland in the brain (called a pineoblastoma). When this happens, itʼs referred to as trilateral retinoblastoma.

Expert review and references

  • Helen Dimaras, PhD
  • Stephanie Kletke, MD, FRCSC
  • American Cancer Society. Retinoblastoma. 2018. https://www.cancer.org/.
  • Cancer Research UK. Retinoblastoma. 2024. https://www.cancerresearchuk.org/.
  • Choudhary MM, Singh AD. Ophthalmic cancers. Raghavan D, Ahluwalia MS, Blanke CD, et al, eds.. Textbook of Uncommon Cancers. 5th ed. Hoboken, NJ: Wiley Blackwell; 2017: Kindle version chapter 68 https://read.amazon.ca/?asin=B06XKD44V3&_encoding=UTF8&ref=dbs_p_ebk_r00_pbcb_rnvc00.
  • Leahey AM, Gombos DS, Chevez-Barrios P. Retinoblastoma. Blaney SM, Adamson PC, Helman LJ (eds.). Pizzo and Pollack's Pediatric Oncology. 8th ed. Wolters Kluwer; 2021: Kindle version, [chapter 32] https://read.amazon.ca/?asin=B08DVWZNVP&language=en-CA.
  • Mallipatna AC, Gallie BL, Chévez-Barrios P, et al. Retinoblastoma. Amin, MB (ed.). AJCC Cancer Staging Manual. 8th ed. Chicago, IL: American College of Surgeons; 2017: 68:827–839.
  • PDQ® Pediatric Treatment Editorial Board. Retinoblastoma Treatment (PDQ®) – Health Professional Version. Bethesda, MD: National Cancer Institute; 2024. https://www.cancer.gov/.

Your trusted source for accurate cancer information

With support from readers like you, we can continue to provide the highest quality cancer information for over 100 types of cancer.

We’re here to ensure easy access to accurate cancer information for you and the millions of people who visit this website every year. But we can’t do it alone.

Every donation helps fund reliable cancer information, compassionate support services and the most promising research. Please give today because every contribution counts. Thank you.

Medical disclaimer

The information that the Canadian Cancer Society provides does not replace your relationship with your doctor. The information is for your general use, so be sure to talk to a qualified healthcare professional before making medical decisions or if you have questions about your health.

We do our best to make sure that the information we provide is accurate and reliable but cannot guarantee that it is error-free or complete.

The Canadian Cancer Society is not responsible for the quality of the information or services provided by other organizations and mentioned on cancer.ca, nor do we endorse any service, product, treatment or therapy.


1-888-939-3333 | cancer.ca | © 2025 Canadian Cancer Society